Silicate fiber-based 3D cell culture system for anticancer drug screening

Anticancer Research

Volumn 33, Issue 12, 2013, Pages 5301-5309

  Yamaguchi, Yoshie ^a   Deng, Dawei ^a   Sato, Yoshinori ^a   Hou, Yung Te ^a   Watanabe, Rie ^b   Sasaki, Kohei ^b   Kawabe, Masaaki ^b   Hirano, Eiichi ^a   Morinaga, Tetsuo ^a  

^a Japan Bio Products Co   (Japan)

^b JAPAN VILENE COMPANY LTD   (Japan)

Author keywords

Anticancer drug screening; Drug resistance; Silicate fiber scaffold; Three dimensional (3D) culture

Indexed keywords

CYCLOOXYGENASE 2; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTIC ACID; MITOMYCIN; MOLECULAR SCAFFOLD; PROTEIN BCL 2; SILICATE; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG UPTAKE; ELECTROSPINNING; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TECHNOLOGY; TUMOR CELL LINE;

EID: 84891416962     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Griffith LG and Swartz MA: Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7: 211-224, 2006.
2. Cukierman E, Pankov R, Stevens DR and Yamada KM: Taking cell-matrix adhesions to the third dimension. Science 294: 1708-1712, 2001.
3. Labarbera DV, Reid BG and Yoo BH: The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin Drug Discov 9: 819-830, 2012.
4. Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES and Mayer LD: Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res 60: 2964-2972, 2000.
5. Torrance CJ, Agrawal V, Vogelstein B and Kinzler KW: Use of isogenic human cancer cells for high-throughput screening and drug discovery. Nat Biotechnol 19: 940-945, 2001.
6. Sutherland RM: Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240: 177-184, 1988.
7. Lin RZ and Chang HY: Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 3: 1172-1184, 2008.
8. Holliday DL, Brouilette KT, Markert A, Gordon LA and Jones JL: Novel multicellular organotypic models of normal and malignant breast: Tools for dissecting the role of the microenvironment in breast cancer progression. Breast Cancer Res 11: R3, 2009.
9. Gurski LA, Jha AK, Zhang C, Jia X and Farach-Carson MC: Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30: 6076-6085, 2009.
10. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ and Mooney DJ: Engineering tumors with 3D scaffolds. Nat Methods 4: 855-860, 2007.
11. Sahoo SK, Panda AK and Labhasetwar V: Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules 6: 1132-1139, 2005.
12. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK and Labhasetwar V: 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 5: 849-862, 2008.
13. Yamaguchi T, Sakai S and Kawakami K: Application of silicate electrospun nanofibers for cell culture. J Sol-Gel Sci Technol 48: 350-355, 2008.
14. Sakai S, Yamaguchi T, Putra RA, Watanabe R, Kawabe M, Taya M and Kawakami K: Controlling apatite microparticles formation by calcining electrospun sol-gel derived ultrafine silica fibers. J Sol-Gel Sci Technol 61: 374-380, 2012.
15. Yamaguchi T, Sakai S, Watanabe R, Tarao T and Kawakami K: Heat treatment of electrospun silicate fiber substrates enhances cellular adhesion and proliferation. J Biosci Bioengin 109: 304-306, 2010.
16. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990.
17. Warburg O: On the original of cancer cells. Science 123: 309-314, 1956.
18. Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, Riker AI, Kamarajugadda S, Lu J, Owen LB, Ledoux SP and Tan M: Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer 9: 33, 2010.
19. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL and Dang CV: Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 107: 2037-2042, 2010.
20. Aggarwal BB: Nuclear factor-κB: The enemy within. Cancer Cell 6: 203-208, 2004.
21. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S and Aggarwal BB: Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX2, MMP9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 125: 2187-2197, 2009.
22. Kim JB: Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15: 365-377, 2005.
23. Pampaloni F, Reynaud EG and Stelzer EH: The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839-845, 2007.
24. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
25. Karikusa F and Sawasaki Y: The restoration of the functions of serially passaged calf hepatocytes by spheroid formation. In Vitro Cell Dev Biol Anim 32: 30-37, 1996.
26. Curran JA, Chen R and Hun JA: The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate. Biomaterials 27: 4783-4793, 2006.
27. Ivascu A and Kubbies M: Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31: 1403-13, 2007.
28. Kyle AH, Huxham LA, Chiam AS, Sim DH and Minchinton AI: Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res 64: 6304-6309, 2004.
29. Grantab R, Sivananthan S and Tannock IF: The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 66: 1033-1039, 2006.
30. Suntherland RM: Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240: 177-184, 1988.
31. Kyle AH and Minchinton AI: Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model. Cancer Chemother Pharmacol 43: 213-220, 1999.
32. Hicks KO, Ohms SJ, van Zijl PL, Denny WA, Hunter PJ and Wilson WR: An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br J Cancer 76: 894-903, 1997.
33. Mitra M, Mohanty C, Harilal A, Maheswari UK, Sahoo SK and Krishnakumar S: A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs. Mol Vis 18: 1361-1378, 2012.
34. Kyle AH, Huxham LA, Yeoman DM and Minchinton AI: Limited tissue penetration of taxanes: A mechanism for resistance in solid tumors. Clin Cancer Res 13: 2804-2810, 2007.
35. Stubbs M, McSheehy PM, Griffiths JR and Bashford CL: Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6: 15-19, 2000.
36. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW and Mueller-Klieser W: Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: 349-353, 2001.
37. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK and Mueller-Klieser W: Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am. J. Pathol 150: 409-415, 1997.
38. Godugu C, Patel AR, Desai U, Andey T, Sams A and Singh M: AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One 8: e53708, 2013.
39. Yang TM, Barbone D, Fennell DA and Broaddus VC: BCL2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. Am J Respir Cell Mol Biol 41: 14-23, 2009.
40. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
41. Koki AT, Leahy KM and Masferrer JL: Potential utility of COX2 inhibitors in chemoprevention and chemotherapy. Expert Opin Investig Drugs 8: 1623-1638, 1999.
42. Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M and Takahashi T: Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 6: 2006-2011, 2000.
43. Tsujii M and DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
44. Sun Y, Tang XM, Half E, Kuo MT and Sinicrope FA: Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 62: 6323-6328, 2002.
45. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998.
46. Pidgeon GP, Barr MP, Harmey JH, Foley DA and Bouchier-Hayes DJ: Vascular endothelial growth factor (VEGF) upregulates BCL2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer 85: 273-278, 2001.